Navigation Links
Celladon Corporation Announces Pre-clinical Study Demonstrating Inhalable MYDICAR Reverses Pulmonary Arterial Hypertension (PAH)
Date:7/30/2013

Janet C. Ross Professor of Medicine and Professor of Gene & Cell at Icahn School of Medicine at Mount Sinai. "We are excited about testing this therapy in PAH patients who are in critical need of intervention."

This same SERCA2a dysfunction also occurs in heart failure. This new study utilizes Celladon's product candidate MYDICAR which is currently under investigation in an international 200 patient Phase IIb trial in the United States and Europe. In 2012, Celladon and the Mt. Sinai School of Medicine entered into a license agreement granting Celladon certain exclusive worldwide rights to develop and commercialize SERCA2a gene therapy products for PAH.

"What we have shown is that gene therapy restores function of this crucial SERCA2a enzyme in diseased lungs," says Dr. Hajjar. "We are delighted with these new findings because it suggests that MYDICAR which is already showing great benefit in congestive heart failure patients may be able to help PAH patients who currently have no good treatment options — and are in critical need of a life sustaining therapy."

When SERCA2a is down-regulated, calcium stays longer in the cells than it should, and it induces pathways that lead to overgrowth of new and enlarged cells. According to researchers, the delivery of the SERCA2a gene through the MYDICAR product in turn produces SERCA2a enzymes, which helps both heart and lung cells restore their proper use of calcium.

"We are now on a path toward PAH patient clinical trials in the near future," says Dr. Hajjar, a co-founder of Celladon who developed the gene therapy approach. Studies in large animal models are now underway. SERCA2a gene therapy has already been approved by the National Institutes of Health for human study.

A Simple MYDICAR Inhalation Corrects Deadly Dysfunction
PAH most commonly results from heart failure in the left side of the heart or from a pulmonary embol
'/>"/>

SOURCE Celladon Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Celladon Corporation Named a 2012 Fierce 15 Company by FierceBiotech
2. Celladon Corporation To Present at BioCentury Future Leaders in the Biotech Industry Conference
3. Celladon Corporation and SIRO Clinpharm Announce Presentation at "Statisticians in the Pharmaceutical Industry International Conference"
4. Celladon Corporation Selected as Winner of Red Herrings "Top 100 North America Tech Startup"
5. China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2012 Financial Results
6. Kensey Nash Corporation Announces Achievement of $6 Million Milestone From Spectranetics Corporation
7. China Cord Blood Corporation Announces Results of 2011 Annual General Meeting
8. Neogen Corporation Announces 2nd Quarter Results Conference Call
9. Luminex Corporation to Present at JP Morgan Healthcare Conference
10. Luminex Corporation Fourth Quarter and Full Year 2011 Earnings Release Scheduled for February 6, 2012
11. Plaintiff Sales Representatives and Novartis Pharmaceuticals Corporation Resolve Class Action Wage and Hour Claims
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , July 24, 2014  CorMedix Inc. (NYSE ... and commercializing therapeutic products for the prevention and ... receipt of notice on July 18, 2014 from ... has accepted the CorMedix plan to regain compliance ... a result, the NYSE-MKT is continuing the Company,s ...
(Date:7/24/2014)... Mich. , July 24, 2014  Neogen Corporation ... that future forecasts of its potential revenue from new ... call to investors and analysts on July 22, 2014, ... by analysts regarding this research. "It was ... questions about the potential of a new type of ...
(Date:7/24/2014)... The first part of the session on ... Human Studies” will cover comprehensive clinical support in early ... increasing R&D costs and declining industry success in getting ... knowledge collected in early Phase I/IIa study data to ... stage development. , Next, the presenters will examine steps ...
(Date:7/24/2014)... , July 24, 2014   Cypher ... today the appointment of Adam Simpson ... Genomics provides rapid and comprehensive annotation and interpretation ... clinical reporting. "Cypher,s technology has the ... healthcare by enhancing diagnostic accuracy, optimizing therapeutic approaches ...
Breaking Biology Technology:CorMedix, Inc. Granted Extension of NYSE-MKT Listing 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 3Neogen comments on SenesTech 2Best Practices for Optimizing Dose Escalation in First in Human Studies, New Webinar August 6th Hosted by Xtalks 2Cypher Genomics Announces the Appointment of Adam Simpson as President and COO to Advance Transformative Genome Interpretation Technology 2Cypher Genomics Announces the Appointment of Adam Simpson as President and COO to Advance Transformative Genome Interpretation Technology 3
... in the sensitivity of weighing scales. Using the same ... functional nanotube radio, researchers with Berkeley Lab and the ... nanoelectromechanical system (NEMS) that can function as a scale ... atom of gold. , Alex Zettl, a physicist who ...
... SAN DIEGO, July 28 Ardea Biosciences, Inc.,(Nasdaq: ... be presented on RDEA806, the,Company,s novel investigational non-nucleoside ... virus (HIV) at,the 48th Annual ICAAC/IDSA 46th Annual ... Dr. Graeme Moyle, Director of HIV Research, Chelsea ...
... at IMAPS 2008 , ... Washington, D.C. (PRWEB) July ... proud to announce that Governor Carcieri and Dr Zolper have agreed ... on Microelectronics (IMAPS ,08) at the Providence, RI, Convention Center, November ...
Cached Biology Technology:Golden scales 2Golden scales 3Ardea to Present Data on Lead HIV Candidate, RDEA806, at ICAAC/IDSA Joint Meeting 2Ardea to Present Data on Lead HIV Candidate, RDEA806, at ICAAC/IDSA Joint Meeting 3Rhode Island Governor Donald L. Carcieri and Dr. John C. Zolper, Vice President, Raytheon Company to Speak at IMAPS 2008 2
(Date:7/24/2014)... cars ply silent freeways, solar panels blanket rooftops and ... from howling winds and from the blazing desert sun. ... technically and economically feasible to convert California,s all-purpose energy ... in Energy , the plan shows the way ... California that could create tens of thousands of jobs ...
(Date:7/24/2014)... research out of York University shows a surprisingly effective ... grass fungus: moose saliva (yes moose saliva). , ... saliva inhibits a grassendophyte mutualism" shows that moose and ... hosts a fungus called epichlo festucae that produces the ... toxicity. , "Plants have evolved defense mechanisms to protect ...
(Date:7/24/2014)... team of researchers has developed a new nanoscale agent ... method for assessing the function and properties of the ... diagnosis and treatment of gut diseases. , ... syndrome and inflammatory bowel disease all occur in the ... patients with diseases such as diabetes and Parkinson,s. ...
Breaking Biology News(10 mins):Stanford study shows how to power California with wind, water and sun 2Stanford study shows how to power California with wind, water and sun 3Stanford study shows how to power California with wind, water and sun 4Moose drool inhibits growth of toxic fungus: York U research 2New imaging agent provides better picture of the gut 2
... children and young adults for influenza is being seriously underestimated, ... historic vaccine programs have concentrated on the elderly and those ... computer modeling analysis was just published in the journal ... Health. The study suggests that children in school and young ...
... June 11, 2013 (BRONX, NY) Today, researchers ... Yeshiva University convened a one-day conference on Jewish genetics ... research. Such research could help scientists identify causes and ... common disorders afflicting the general population. The ...
... guarantee future support for international scientific collaborations funded by ... on a three year budgetary framework will extend the ... At an Intergovernmental Conference hosted by the European Commission ... governments that support the Human Frontier Science Program came ...
Cached Biology News:Flu vaccines aimed at younger populations could break annual transmission cycle 2Flu vaccines aimed at younger populations could break annual transmission cycle 3Albert Einstein College of Medicine hosts conference on Jewish genetic research 2
...
Request Info...
Streptomycin sulfate an aminoglycoside used for bacterial selection binds to the small ribosomal subunit and interferes with protein biosynthesis.21H39N7O12)2x3H2SO4Formula weight:...
Adducin beta (C-16)...
Biology Products: